Clinical Research Directory
Browse clinical research sites, groups, and studies.
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
Sponsor: First Affiliated Hospital of Fujian Medical University
Summary
To evaluate the potential usefulness of 68Ga-DOTA/NOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer.
Official title: 68Ga-DOTA/NOTA-FAPI-04 PET/CT in Patients With Various Types of Cancer
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
500
Start Date
2020-08-15
Completion Date
2027-12-30
Last Updated
2026-07-21
Healthy Volunteers
No
Interventions
68Ga-DOTA/NOTA-FAPI-04
Each patient receive a single intravenous injection of 68Ga-DOTA/NOTA-FAPI-04, and undergo PET/CT scan within specified time.
PET/CT scan
PET/CT scan
Locations (1)
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China